Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jad Othman

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 20, 2020
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearanceJulian Lindsay, Jad Othman, Ian Kerridge, et al.
Pathology|January 24, 2026
Measurable Residual Disease detection in Acute Lymphoblastic Leukaemia - comparison between targeted NGS and ASO-RQPCRJared Lane, Royston Ponraj, Jad Othman, et al.
Blood|November 1, 2024
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AMLCurtis A Lachowiez, Vishvaas I Ravikumar, Jad Othman, et al.
Transplantation and Cellular Therapy|November 29, 2023
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular TherapiesEdward Abadir, Jad Othman, John Kwan, et al.
Pathology|December 4, 2020
Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiativeGreg Corboy, Jad Othman, Linda Lee, et al.
Leukemia|September 11, 2025
Acute myeloid leukaemia cells express high levels of androgen receptor but do not depend on androgen signaling for survivalFarideh Miraki-Moud, Linda Ariza-McNaughton, Thinzar KoKo, et al.
Blood Advances|September 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AMLNigel Russell, Jad Othman, Oliver Cumming, et al.
Open Forum Infectious Diseases|May 13, 2022
SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell TransplantationJulian Lindsay, Jad Othman, Yvonne Kong, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 28, 2021
Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplantJulian Lindsay, Jad Othman, Michelle K Yong, et al.
Internal Medicine Journal|March 6, 2023
Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysisRichard Blennerhassett, Jad Othman, Amber Biscoe, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 20, 2020
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearanceJulian Lindsay, Jad Othman, Ian Kerridge, et al.
Pathology|January 24, 2026
Measurable Residual Disease detection in Acute Lymphoblastic Leukaemia - comparison between targeted NGS and ASO-RQPCRJared Lane, Royston Ponraj, Jad Othman, et al.
Blood|November 1, 2024
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AMLCurtis A Lachowiez, Vishvaas I Ravikumar, Jad Othman, et al.
Transplantation and Cellular Therapy|November 29, 2023
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular TherapiesEdward Abadir, Jad Othman, John Kwan, et al.
Pathology|December 4, 2020
Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiativeGreg Corboy, Jad Othman, Linda Lee, et al.
Leukemia|September 11, 2025
Acute myeloid leukaemia cells express high levels of androgen receptor but do not depend on androgen signaling for survivalFarideh Miraki-Moud, Linda Ariza-McNaughton, Thinzar KoKo, et al.
Blood Advances|September 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AMLNigel Russell, Jad Othman, Oliver Cumming, et al.
Open Forum Infectious Diseases|May 13, 2022
SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell TransplantationJulian Lindsay, Jad Othman, Yvonne Kong, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 28, 2021
Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplantJulian Lindsay, Jad Othman, Michelle K Yong, et al.
Internal Medicine Journal|March 6, 2023
Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysisRichard Blennerhassett, Jad Othman, Amber Biscoe, et al.
Pageof 5